The current success of drugs blocking TNF-α as well as IL-17A receptors in the treatment of rheumatoid joints confirms that TNF-α and IL-17A mediated transmissions play a key role in rheumatoid arthritis [33]. Here, TNF is linked to rheumatoid arthritis.